XML 25 R15.htm IDEA: XBRL DOCUMENT
v3.22.2.2

RISKS AND UNCERTAINTIES | 9 Months Ended
--- | ---
Sep. 30, 2022
Risks and Uncertainties [Abstract] |
RISKS AND UNCERTAINTIES | NOTE 8 – RISKS AND UNCERTAINTIES Concentration Risk The table below shows customers who account for 10% or more of the Company’s total revenues and 10% or more of the Company’s accounts receivable for the periods presented: Customers exceeding 10% of revenue: SCHEDULES OF CONCENTRATION OF RISK
|  | Three Months Ended September 30, |  |  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |  |  | Nine Months Ended September 30, |
Company Customer Number |  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
C000001462 |  |  | * |  |  |  | 58 | % |  |  | 12 | % |  |  | 51 | %
C000001140 |  |  | * |  |  |  | * |  |  |  | 16 | % |  |  | * |
C000001696 |  |  | 12 | % |  |  | * |  |  |  | * |  |  |  | * |
Customers exceeding 10% of accounts receivable:
|  | September 30, |  |  | December 31, |
Company Customer Number |  | 2022 |  |  | 2021 |
C000001462 |  |  | * |  |  |  | 41 | %
C000001140 |  |  | 14 | % |  |  | 23 | %
C000002187 |  |  | 22 | % |  |  | * |
The table below shows vendors who account for 10% or more of the Company’s total purchases and 10% or more of the Company’s accounts payable for the periods presented: Vendors exceeding 10% of purchases:
|  | Three Months Ended September 30, |  |  | Three Months Ended September 30, |  |  | Nine Months Ended September 30, |  |  | Nine Months Ended September 30, |
Company Vendor Number |  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
V000001029 |  |  | * |  |  |  | 10 | % |  |  | 19 | % |  |  | * |
V000000453 |  |  | * |  |  |  | 18 | % |  |  | * |  |  |  | 13 | %
V000001326 |  |  | 10 | % |  |  | 18 | % |  |  | * |  |  |  | 13 | %
V000001372 |  |  | * |  |  |  | 15 | % |  |  | * |  |  |  | 15 | %
Vendors exceeding 10% of accounts payable:
|  | September 30, |  |  | December 31, |
Company Vendor Number |  | 2022 |  |  | 2021 |
V000000453 |  |  | * |  |  |  | 20 | %
V000001372 |  |  | * |  |  |  | 33 | %
V000001326 |  |  | * |  |  |  | 12 | %
V000001740 |  |  | 14 | % |  |  | * |
V000001818 |  |  | 15 | % |  |  | * |
*Amounts less than 10% Foreign Exchange Risk Although the Company’s revenues and expenses are expected to be predominantly denominated in United States dollars, the Company may be exposed to currency exchange fluctuations. Recent events in the global financial markets have been coupled with increased volatility in the currency markets. Fluctuations in the exchange rate between the U.S. dollar, the Canadian dollar, the Euro, and the currency of other regions in which the Company may operate may have a material adverse effect on the Company’s business, financial condition and operating results. The Company may, in the future, establish a program to hedge a portion of the Company’s foreign currency exposure with the objective of minimizing the impact of adverse foreign currency exchange movements. However, even if the Company develops a hedging program, there can be no assurance that it will effectively mitigate currency risks.

X
- Definition The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -URI https://asc.fasb.org/topic&trid=2134479 + Details
Name: | us-gaap_ConcentrationRiskDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RisksAndUncertaintiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration